Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
Animal studies show TB-500 reduces endometrial implant size by up to 60% and significantly decreases adhesion formation compared to controls
TB-500 (synthetic TB4) has been clinically tested for its wound healing potential, with the following two studies worth noting: In a randomized, double-blind, placebo-controlled study with dose escalation, patients suffering from venous stasis ulcers were administered synthetic TB4 locally over a period of 84 days
Neuroprotective Properties In addition to sleep research, DSIP has been investigated in models of neuroprotection and adaptation to environmental stressors
There may be some amount of discomfort during the administration which is usually tolerable
When your body is not adapted to this effect, the result is nausea, sometimes severe enough to stop the protocol entirely
